FGF18 and cancer: In 103 OC patient samples, FGF18 expression was increased in serous and mucinous ovarian cancers by IHC as well as analysis of clinicopathological variables and patient outcomes, and was similarly significantly increased from adenoma to borderline tumor to type I cancer and then from type I to type II cancer (88).